Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

RVC study reveals benefits of feline epicardial pacemakers
Cats are less likely to be considered for EP implantation.
EPs improved severe heart conditions in cats.

Research from the Royal Veterinary College (RVC) has found that epicardial pacemakers (EPs) can result in positive outcomes for cats suffering from severe heart conditions.

Findings revealed that EP implantation supported artificial cardiac pacing (ACP), which was effective in resolving symptoms such as abnormally slow heart rates (bradyarrhythmia).

Cats are less likely to be considered for EP implantation, as they are better at tolerating bradyarrhythmia. It is usually reserved for cats displaying symptoms such as loss of consciousness, lethargy or a congestive heart.

There was also a lack of research into performing the procedure and the outcomes on quality of life.

A research team, led by Matteo Rossanese, investigated the outcomes of implantations for 39 cats across four animal hospitals. Using a two-part survey, the team sought to identify the clinical signs and health-related quality of life by measuring cat activity and owner satisfaction.

The findings confirmed that EP was a beneficial surgery for cats, contributing to a longer, better quality of life for cats.

The primary reasons that cats were referred for treatment included bradycardia and collapsing episodes. A third-degree atrioventricular block was found to be the most common indicator of pacemaker placement.

Owners reported a good improvement in their cat’s condition, rating their satisfaction at 9.9 out of 10.

The research team says that their findings also highlight the importance of a joined up approach between cardiology and cardiothoracic specialists in these cases.

Dr Rossanese, senior lecturer in small animal soft tissue surgery, said: “I am incredibly proud of the work our team has done to explore the use of epicardial pacemakers in cats.

“This study not only highlights the potential for significant improvements in quality of life for feline patients but also provides valuable evidence to guide clinicians in making confident decisions about this life-changing procedure.

“It has been a privilege to lead this study alongside a dedicated team of colleagues, and I hope these findings will encourage further advancements in veterinary cardiology.”

The full study can be found in the Journal of the American Veterinary Medical Association.

Image © RVC

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.